Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
Randomized, Open-Label, Active-Controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa Randomized, Open-Label, Active-Controlled, Multicenter Study to Assess theEfficacy, Safety and Toler ...
Pseudomonas Aeruginosa Infection
Drug: Liposomalamikacinforinhalation(Arikayce™)usingthePARIInvestigationaleFlow®Nebulizer.;Drug: Tobramycin inhalation solution using a PARI LC® Plus nebulizer.Drug: Liposomalamikacinforinhalation(Arikayce™)usingthePARIInvestigationaleFlow®Nebulizer. ...